Sensei Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $-4,851 | $0 | $0 | $544 |
Gross Profit | -37 | -30 | -139 | |
EBITDA | -4,529 | -4,889 | -6,821 | -7,614 |
EBIT | -4,563 | -4,926 | -6,851 | -7,753 |
Net Income | -4,569 | -4,936 | -6,864 | -7,770 |
Net Change In Cash | -4,851 | 0 | 0 | 544 |
Free Cash Flow | -3,586 | -5,925 | -7,094 | -5,792 |
Cash | 10,562 | 12,557 | 9,877 | 9,994 |
Basic Shares | 1,261 | 1,260 | 25,192 | 25,165 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -551 | -571 | -1,808 | -685 |
EBITDA | -29,516 | -33,386 | -48,841 | -35,439 |
EBIT | -30,067 | -37,064 | -50,188 | -36,124 |
Net Income | -30,157 | -34,101 | -48,807 | -36,794 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -24,816 | -32,203 | -39,347 | -32,285 |
Cash | 9,994 | 13,011 | 17,795 | 7,159 |
Basic Shares | 25,117 | 27,952 | 30,703 | 27,710 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$3.62 |
2025-06-30 | -$3.91 |
2025-03-31 | -$0.27 |
2024-12-31 | -$0.27 |
